All Updates

All Updates

icon
Filter
Funding
Van Heron Labs raises USD 1.1 million in seed funding to advance technology platform
Cell-cultured Meat
Mar 5, 2024
This week:
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Product updates
Uber releases five new features for holiday travel season
Travel Tech
Yesterday
Funding
Apaleo raises EUR 20 million in growth equity funding to accelerate expansion
Travel Tech
Yesterday
Partnerships
Acai Travel partners with Hopper to enhance call center operations with AI technology
Travel Tech
Yesterday
Cell-cultured Meat

Cell-cultured Meat

Mar 5, 2024

Van Heron Labs raises USD 1.1 million in seed funding to advance technology platform

Funding

  • Biotech firm Van Heron Labs, which specializes in precision nutrition for cell growth, has raised USD 1.1 million in seed funding led by FoodLabs.

  • The funding will be used to improve Van Heron's technology platform and commercialize its product offerings and services.

  • Established in 2020, Van Heron Labs utilizes genomics, bioinformatics, AI, and nanotechnology for cellular nutrition solutions, including basal media, supplements, feeds, and bioreactor additives. Its proprietary media formulation platform claims to enhance cell vitality, growth, and efficiency and cater to segments like cultivated meat and biomaterials.

  • Analyst QuickTake: Apart from its media formulations platform, the company has also developed Ser-X Technology to help companies transition from using fetal bovine serum (FBS). Using FBS for cell culture has been linked to ethical concerns and contamination risks, which has led to a push to replace FBS with serum-free alternatives. Ven Heron Labs could use the new funding and technology to capitalize on this trend.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.